GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
8I5Y | O60939 | Structure of human Nav1.7 in complex with vixotrigine | |
5U74 | O15118 | Structure of human Niemann-Pick C1 protein | |
1W6K | P48449 | Structure of human OSC in complex with Lanosterol | |
1W6J | P48449 | Structure of human OSC in complex with Ro 48-8071 | |
6AH4 | P56373 | Structure of human P2X3 receptor in complex with ATP and Ca2+ ion | P2X purinoceptor 3 |
6AH5 | P56373 | Structure of human P2X3 receptor in complex with ATP and Mg2+ ion | P2X purinoceptor 3 |
6OEU | Q13635 | Structure of human Patched1 | |
6OEV | Q13635 | Structure of human Patched1 in complex with native Sonic Hedgehog | Protein patched homolog 1, Sonic hedgehog protein |
6OEV | Q15465 | Structure of human Patched1 in complex with native Sonic Hedgehog | Protein patched homolog 1, Sonic hedgehog protein |
7XLQ | Q15878 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the ligand-free (apo) state | |
7XLQ | Q02641 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the ligand-free (apo) state | |
7XLQ | P54289 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the ligand-free (apo) state | |
7YG5 | Q15878 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the topiramate-bound state | |
7YG5 | Q02641 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the topiramate-bound state | |
7YG5 | P54289 | Structure of human R-type voltage-gated CaV2.3-alpha2/delta1-beta1 channel complex in the topiramate-bound state | |
7SN2 | P0DTC2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
7SN2 | 7SN2 | Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab | |
7SN3 | P0DTC2 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
7SN3 | 7SN3 | Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (variable region) | |
7YNI | P13866 | Structure of human SGLT1-MAP17 complex bound with substrate 4D4FDG in the occluded conformation | |
7YNI | Q13113 | Structure of human SGLT1-MAP17 complex bound with substrate 4D4FDG in the occluded conformation | |
7YNJ | P31639 | Structure of human SGLT2-MAP17 complex bound with substrate AMG in the occluded conformation | |
7YNJ | Q13113 | Structure of human SGLT2-MAP17 complex bound with substrate AMG in the occluded conformation | |
8HDH | P31639 | Structure of human SGLT2-MAP17 complex with Canagliflozin | |
8HDH | Q13113 | Structure of human SGLT2-MAP17 complex with Canagliflozin | |
8HEZ | P31639 | Structure of human SGLT2-MAP17 complex with Dapagliflozin | |
8HEZ | Q13113 | Structure of human SGLT2-MAP17 complex with Dapagliflozin | |
8HIN | P31639 | Structure of human SGLT2-MAP17 complex with Phlorizin | |
8HIN | Q13113 | Structure of human SGLT2-MAP17 complex with Phlorizin | |
8HG7 | P31639 | Structure of human SGLT2-MAP17 complex with Sotagliflozin | |
8HG7 | Q13113 | Structure of human SGLT2-MAP17 complex with Sotagliflozin | |
8HB0 | P31639 | Structure of human SGLT2-MAP17 complex with TA1887 | |
8HB0 | Q13113 | Structure of human SGLT2-MAP17 complex with TA1887 | |
8P2W | Q9BYF1 | Structure of human SIT1 (focussed map / refinement) | |
8P2W | Q9NP91 | Structure of human SIT1 (focussed map / refinement) | |
8P2Z | Q9BYF1 | Structure of human SIT1 bound to L-pipecolate (focussed map / refinement) | |
8P2Z | Q9NP91 | Structure of human SIT1 bound to L-pipecolate (focussed map / refinement) | |
8P2Y | Q9BYF1 | Structure of human SIT1:ACE2 complex (closed PD conformation) | |
8P2Y | Q9NP91 | Structure of human SIT1:ACE2 complex (closed PD conformation) | |
8P31 | Q9BYF1 | Structure of human SIT1:ACE2 complex (closed PD conformation) bound to L-pipecolate | |
8P31 | Q9NP91 | Structure of human SIT1:ACE2 complex (closed PD conformation) bound to L-pipecolate | |
8P2X | Q9BYF1 | Structure of human SIT1:ACE2 complex (open PD conformation) | |
8P2X | Q9NP91 | Structure of human SIT1:ACE2 complex (open PD conformation) | |
8P30 | Q9BYF1 | Structure of human SIT1:ACE2 complex (open PD conformation) bound to L-pipecolate | |
8P30 | Q9NP91 | Structure of human SIT1:ACE2 complex (open PD conformation) bound to L-pipecolate | |
8SKV | P01876 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
8SKV | P01833 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
8SKV | P01591 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
8SKV | P13050 | Structure of human SIgA1 in complex with Streptococcus pyogenes protein M4 (Arp4) | |
8SKU | P01876 | Structure of human SIgA1 in complex with human CD89 (FcaR1) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024